IL-6 | IL-8 | CCL2 | IL-10 | CXCL10 | VEGF | FGF2** | CX3CL1** | |
---|---|---|---|---|---|---|---|---|
IL-6 | 1 | |||||||
IL-8 | 0.42**† | 1 | ||||||
CCL2 | 0.47**† | 0.42**† | 1 | |||||
IL-10 | 0.59**† | 0.23* | 0.36**† | 1 | ||||
CXCL10 | 0.42**† | 0.20* | 0.41**† | 0.41**† | 1 | |||
VEGF | 0.49**† | 0.37**† | 0.35**† | 0.41**† | 0.32**† | 1 | ||
FGF2** | NS | NS | 0.25* | 0.35**† | 0.28*† | 0.38*† | 1 | |
CX3CL1** | NS | NS | NS | 042**† | 0.17* | 0.21* | 0.34**† | 1 |
ESR | 0.22* | NS | NS | NS | NS | NS | NS | NS |
↵* 0.0001 ≤ p ≤ 0.02;
↵** p < 0.0001;
** Dichotomous variables.
↵† Significant after Bonferroni correction. NS: not significant; IL: interleukin; VEGF: vascular endothelial growth factor; FGF2: fibroblast growth factor 2; CCL2: chemokine (C-C motif) ligand 2; CXCL10: chemokine (C-X-C motif) ligand 10; CX3CL1: chemokine (C-X3-C motif) ligand 1; ESR: erythrocyte sedimentation rate.